Dobutamine Rate Calculation
Dobutamine infusion rate is calculated using the formula: (Dose in mcg/kg/min × Patient weight in kg × 60 min/hr) ÷ Concentration in mcg/mL = mL/hr, with standard dosing starting at 2-3 mcg/kg/min and titrating up to a typical therapeutic range of 2-20 mcg/kg/min based on clinical response. 1, 2, 3
Standard Dosing Algorithm
Initial dose: Start at 0.5-1.0 mcg/kg/min for cautious initiation, or 2-3 mcg/kg/min for standard initiation, without a loading dose 1, 3
Titration strategy:
- Increase dose every 15 minutes based on clinical response 1
- Double the dose at each titration step according to response or tolerability 1
- Typical therapeutic range is 2-20 mcg/kg/min 1, 2, 3
- Rarely, doses up to 40 mcg/kg/min may be required 3
Preparation and Concentration
Standard concentrations for infusion: 3
- 500 mcg/mL (most common)
- 1,000 mcg/mL
- 2,000 mcg/mL
- Up to 5,000 mcg/mL has been used in fluid-restricted patients 3
Dilution requirement: Must be diluted to at least 50 mL total volume using compatible IV solutions (5% Dextrose, 0.9% Normal Saline, Lactated Ringer's, etc.) 3
Stability: Use within 24 hours of preparation 3
Calculation Examples
For a 70 kg patient receiving 5 mcg/kg/min using 1,000 mcg/mL concentration:
(5 mcg/kg/min × 70 kg × 60 min/hr) ÷ 1,000 mcg/mL = 21 mL/hr 3
For the same patient at 10 mcg/kg/min:
(10 mcg/kg/min × 70 kg × 60 min/hr) ÷ 1,000 mcg/mL = 42 mL/hr 3
Context-Specific Dosing
For stress echocardiography (low-flow/low-gradient aortic stenosis):
- Start at 5 mcg/kg/min 4, 5
- Increase in 5 mcg/kg/min increments every 5 minutes 4, 5
- Maximum dose 20 mcg/kg/min 4, 5
- Terminate when 20% increase in stroke volume achieved (usually at 10 mcg/kg/min) 5
For acute heart failure/cardiogenic shock:
- Start at 2-3 mcg/kg/min 1, 2
- Titrate up to 15-20 mcg/kg/min based on perfusion endpoints 1, 2
- Monitor urine output (target >100 mL/hr in first 2 hours), skin perfusion, mental status 1
For patients on chronic beta-blockers:
- May require doses up to 20 mcg/kg/min to overcome receptor blockade 1, 2
- Consider switching to phosphodiesterase inhibitors (milrinone) if inadequate response at 15-20 mcg/kg/min 2
Critical Monitoring Parameters
Continuous monitoring required: 1, 2
- ECG telemetry for arrhythmias (both atrial and ventricular)
- Blood pressure (invasive arterial line preferred in hypotensive patients)
- Heart rate (watch for excessive tachycardia, especially in atrial fibrillation)
- Urine output
- Signs of perfusion (skin temperature, mental status, lactate)
Dose-limiting factors: 1
- Excessive tachycardia
- Ventricular or atrial arrhythmias
- Myocardial ischemia/chest pain
- In atrial fibrillation: rapid ventricular response due to enhanced AV conduction
Important Clinical Caveats
Tolerance develops after 24-48 hours of continuous infusion, resulting in partial loss of hemodynamic effects 2
Weaning strategy: Decrease by 2 mcg/kg/min every other day while optimizing oral vasodilator therapy 1, 2
Pharmacokinetic variability: There is significant inter- and intrapatient variability in dobutamine clearance (range 19-120 mL/kg/min), with the greatest changes occurring in the first 24 hours of therapy 6. This explains why identical infusion rates produce widely different plasma concentrations and clinical responses 6.
Hemodynamic effects are dose-dependent: 1
- At 2-3 mcg/kg/min: Mild arterial vasodilation with afterload reduction
- At 3-5 mcg/kg/min: Predominant inotropic effects
- At >5 mcg/kg/min: Both inotropic effects and potential vasoconstriction
- At >10 mcg/kg/min: Increased risk of tachycardia and arrhythmias
At low plasma concentrations, cardiac output increases primarily through improved contractility and stroke volume; at higher concentrations, stroke volume plateaus or decreases, and further increases in cardiac output are entirely heart rate-dependent 7. This explains why some patients develop problematic tachycardia at higher doses.